QSOX2
Sulfhydryl oxidase 2
Also known as: DKFZp762A2013, QSCN6L1, QSOX2_HUMAN, SOXN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZRP7
- Gene
- QSOX2
- Ensembl
- ENSG00000165661
- Chromosome
- 9
- Canonical length
- 698 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
QSOX2 is a member of the sulfhydryl oxidase/quiescin-6 (Q6) family (QSOX1; MIM 603120) that regulates the sensitization of neuroblastoma cells for IFN-gamma (IFNG; MIM 147570)-induced cell death (Wittke et al., 2003 [PubMed 14633699]).[supplied by OMIM, Jun 2009]
Canonical amino-acid sequenceUniProt
698 residues, UniProt reviewed canonical sequence.
>Q6ZRP7|QSOX2
1 MAAAGAAVAR SPGIGAGPAL RARRSPPPRA ARLPRLLVLL AAAAVGPGAG GAARLYRAGE
61 DAVWVLDSGS VRGATANSSA AWLVQFYSSW CGHCIGYAPT WRALAGDVRD WASAIRVAAL
121 DCMEEKNQAV CHDYDIHFYP TFRYFKAFTK EFTTGENFKG PDRELRTVRQ TMIDFLQNHT
181 EGSRPPACPR LDPIQPSDVL SLLDNRGSHY VAIVFESNSS YLGREVILDL IPYESIVVTR
241 ALDGDKAFLE KLGVSSVPSC YLIYPNGSHG LINVVKPLRA FFSSYLKSLP DVRKKSLPLP
301 EKPHKEENSE IVVWREFDKS KLYTVDLESG LHYLLRVELA AHKSLAGAEL KTLKDFVTVL
361 AKLFPGRPPV KKLLEMLQEW LASLPLDRIP YNAVLDLVNN KMRISGIFLT NHIKWVGCQG
421 SRSELRGYPC SLWKLFHTLT VEASTHPDAL VGTGFEDDPQ AVLQTMRRYV HTFFGCKECG
481 EHFEEMAKES MDSVKTPDQA ILWLWKKHNM VNGRLAGHLS EDPRFPKLQW PTPDLCPACH
541 EEIKGLASWD EGHVLTFLKQ HYGRDNLLDT YSADQGDSSE GGTLARGEEE EKRLTPPEVS
601 HGDRDTQSVR PPGALGPRPA LPESLHHSLD GKLQSLDGPG AHKEVGGAAP FLGVDFSSLD
661 MSLCVVLYVA SSLFLMVMYF FFRVRSRRWK VKHHHPAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against QSOX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 31 nTPM
- cerebellum: 31 nTPM
- pancreas: 18 nTPM
- spleen: 15 nTPM
- thyroid gland: 11 nTPM
- small intestine: 11 nTPM
Single-cell type
- lactotrophs: 121 nCPM
- somatotrophs: 95 nCPM
- thyrotrophs: 91 nCPM
- gonadotrophs: 54 nCPM
- pancreatic islet cells: 40 nCPM
- b-cells: 36 nCPM
Immune cell
- basophil: 0.3 nTPM
- eosinophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 20 nTPM
- cerebral cortex: 13 nTPM
- hypothalamus: 13 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 12 nTPM
- basal ganglia: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thioredoxin domain
- ERV/ALR sulfhydryl oxidase domain
- Thioredoxin-like superfamily
- ERV/ALR sulfhydryl oxidase domain superfamily
- Sulfhydryl oxidase
- Sulfhydryl oxidase, flavin adenine dinucleotide (FAD) binding domain
- Sulfhydryl oxidase, Trx-like domain
- Sulfhydryl oxidase, flavin adenine dinucleotide (FAD) binding domain superfamily
- Thioredoxin
- Erv1 / Alr family
- QSOX Trx-like domain
- Flavin adenine dinucleotide (FAD)-dependent sulfhydryl oxidase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads QSOX2 as an antibody target. Whether an autoantibody or antibody against QSOX2 could matter depends on whether native QSOX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
QSOX2 is annotated at the cell surface, where native QSOX2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label QSOX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...